An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
HSG
Activity from announced rounds
HSG is the investment firm formerly known as Sequoia China, as identified in Clipto’s financing release. Full-Life also names it in its own announcement.
Recorded funding activity
The recorded activity includes Anew’s AI drug discovery, Clipto’s video-library tools and Math Magic’s generation of 3D models and physical products. Named HSG funds retain their separate identities.
Sources
- Rounds participated in
- 7
- Confirmed lead rounds
- 1 6 roles undisclosed
- New companies
- 7 First participation on record · 0 follow-on
- Funding in participating rounds
- $801M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
7 in this selectionAI platform generating 3D models and personalized physical products
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing
Builds humanoid robots with fully in-house hardware for logistics and industrial deployment at scale
Develops interventional therapies for pulmonary hypertension and heart failure
Pan-regional intercollegiate basketball league connecting Asia's top university programs
Develops intelligent, logic-gated therapeutics for solid tumors